{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:09:42Z","timestamp":1783199382295,"version":"3.54.6"},"reference-count":59,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["209265"],"award-info":[{"award-number":["209265"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wellcomeopenresearch.org"],"crossmark-restriction":false},"short-container-title":["Wellcome Open Res"],"abstract":"<ns4:p>\n                    Background African children with cerebral malaria and seizures caused\n                    <ns4:italic>Plasmodium falciparum<\/ns4:italic>\n                    are at greater risk of poor outcomes including death and neurological sequelae. The agonal events are severe hypoventilation and respiratory arrest often triggered by seizures. We hypothesised that prophylactic anti-seizure medication (ASM) could avert \u2018spikes\u2019 of intracranial pressure during or following seizures and that adequate ventilation could be supported by biphasic Cuirass Ventilation (BCV) which requires no intubation. Methods A Phase I trial conducted in Kilifi, Kenya designed to provide data on safety, feasibility and preliminary data on seizure control using prophylactic ASM (levetiracetam) and BCV as non-invasive ventilatory support in children with cerebral malaria. Children aged 3 months to 12-years hospitalised with\n                    <ns4:italic>P falciparum<\/ns4:italic>\n                    malaria (positive rapid diagnostic test or a malaria slide), a Blantyre Coma Score \u22642 and a history of acute seizures in this illness are eligible for the trial. In a phased evaluation we will study i) BCV alone for respiratory support (n=10); ii) prophylactic LVT: 40mg\/kg loading dose then 30mg\/kg every 12 hours given via nasogastric tube for 72 hours (or until fully conscious) plus BCV support (n=10) and; iii) prophylactic LVT: 60mg\/kg loading dose then 45mg\/kg every 12 hours given via nasogastric tube for 72 hours (or until fully conscious) plus BCV support (n=10). Primary outcome measure: cumulative time with a clinically detected seizures or number of observed seizures over 36 hours. Secondary outcomes will be assessed by feasibility or ability to implement BCV, and recovery from coma within 36 hours. Safety endpoints include: aspiration during admission; death at 28 days and 180 days; and de-novo neurological impairments at 180 days. Conclusions This is a Phase I trial largely designed to test the feasibility, tolerability and safety of using non-invasive ventilatory support and LVT prophylaxis in cerebral malaria. Registration ISRCTN76942974 (5.02.2019); PACTR202112749708968 (20.12.2021).\n                  <\/ns4:p>","DOI":"10.12688\/wellcomeopenres.21403.1","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T05:45:08Z","timestamp":1716183908000},"page":"281","update-policy":"https:\/\/doi.org\/10.12688\/wellcomeopenres.crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A Phase I trial of Non-invasive\u00a0Ventilation\u00a0and seizure prophylaxis with levetiracetam In\u00a0Children with\u00a0Cerebral Malaria Trial (NOVICE-M Trial)"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-8109","authenticated-orcid":false,"given":"Kathryn","family":"Maitland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5040-4359","authenticated-orcid":false,"given":"Nchafasto","family":"Obonyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0266-1414","authenticated-orcid":false,"given":"Mainga","family":"Hamaluba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Ogoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christabel","family":"Mogaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6999-5507","authenticated-orcid":false,"given":"Charles","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3934-5132","authenticated-orcid":false,"given":"Symon M.","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-5490","authenticated-orcid":false,"given":"Diana M.","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-4336","authenticated-orcid":false,"given":"Roisin","family":"Connon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"1647-57","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.","volume":"376","author":"A Dondorp","year":"2010","journal-title":"Lancet."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"476-81","DOI":"10.1136\/jnnp.2004.043893","article-title":"Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children.","volume":"76","author":"J Carter","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"441-59","DOI":"10.1093\/oxfordjournals.qjmed.a068338","article-title":"Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.","volume":"71","author":"M Molyneux","year":"1989","journal-title":"Q J Med."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"161-5","DOI":"10.1016\/s0035-9203(97)90207-8","article-title":"Coma scales for children with severe falciparum malaria.","volume":"91","author":"C Newton","year":"1997","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"ref-5","first-page":"35-8","article-title":"Malaria--clinical features in children.","volume":"82 Suppl 17","author":"M Molyneux","year":"1989","journal-title":"J R Soc Med."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"1173-81","DOI":"10.1016\/S1474-4422(10)70270-2","article-title":"Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study.","volume":"9","author":"G Birbeck","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"591-7","DOI":"10.1093\/qjmed\/89.8.591","article-title":"Seizures and status epilepticus in childhood cerebral malaria.","volume":"89","author":"J Crawley","year":"1996","journal-title":"QJM."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"1519-28","DOI":"10.1093\/brain\/awr051","article-title":"Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast.","volume":"134","author":"S Kariuki","year":"2011","journal-title":"Brain."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"1039-43","DOI":"10.1016\/0140-6736(90)92498-7","article-title":"Neurological sequelae of cerebral malaria in children.","volume":"336","author":"D Brewster","year":"1990","journal-title":"Lancet."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"17-9","DOI":"10.1016\/0035-9203(92)90420-h","article-title":"The incidence and outcome of neurological abnormalities in childhood cerebral malaria: a long-term follow-up of 62 survivors.","volume":"86","author":"F Bondi","year":"1992","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"ref-11","first-page":"49-53","article-title":"Cerebral malaria in non-paediatric subjects resident in southwestern Nigeria.","volume":"22","author":"A Sowunmi","year":"1993","journal-title":"Afr J Med Med Sci."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"1-53","DOI":"10.1016\/s0163-7258(98)00008-4","article-title":"Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment.","volume":"79","author":"C Newton","year":"1998","journal-title":"Pharmacol Ther."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"e360-6","DOI":"10.1542\/peds.2006-2027","article-title":"Cognitive impairment after cerebral malaria in children: a prospective study.","volume":"119","author":"M Boivin","year":"2007","journal-title":"Pediatrics."},{"key":"ref-14","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-104","article-title":"Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children.","volume":"3","author":"R Idro","year":"2010","journal-title":"BMC Res Notes."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"827-40","DOI":"10.1016\/S1474-4422(05)70247-7","article-title":"Pathogenesis, clinical features, and neurological outcome of cerebral malaria.","volume":"4","author":"R Idro","year":"2005","journal-title":"Lancet Neurol."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"142-8","DOI":"10.1136\/adc.2005.077784","article-title":"Risk factors for persisting neurological and cognitive impairments following cerebral malaria.","volume":"91","author":"R Idro","year":"2006","journal-title":"Arch Dis Child."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"673-707","DOI":"10.1146\/annurev.micro.55.1.673","article-title":"Antigenic variation at the infected red cell surface in malaria.","volume":"55","author":"S Kyes","year":"2001","journal-title":"Annu Rev Microbiol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"439-50","DOI":"10.1128\/CMR.13.3.439","article-title":"Molecular aspects of severe malaria.","volume":"13","author":"Q Chen","year":"2000","journal-title":"Clin Microbiol Rev."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"228-32","DOI":"10.1016\/s0169-4758(00)01666-5","article-title":"Abnormal blood flow and red blood cell deformability in severe malaria.","volume":"16","author":"A Dondorp","year":"2000","journal-title":"Parasitol Today."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"1742-6","DOI":"10.1086\/315078","article-title":"Cytokine expression in the brain in human Cerebral Malaria.","volume":"180","author":"H Brown","year":"1999","journal-title":"J Infect Dis."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"331-40","DOI":"10.1046\/j.1365-2990.1999.00188.x","article-title":"Evidence of blood-brain barrier dysfunction in human cerebral malaria.","volume":"25","author":"H Brown","year":"1999","journal-title":"Neuropathol Appl Neurobiol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"207-13","DOI":"10.4269\/ajtmh.2001.64.207","article-title":"Blood-brain barrier function in cerebral malaria in Malawian children.","volume":"64","author":"H Brown","year":"2001","journal-title":"Am J Trop Med Hyg."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"219-26","DOI":"10.1136\/adc.76.3.219","article-title":"Intracranial hypertension in Africans with cerebral malaria.","volume":"76","author":"C Newton","year":"1997","journal-title":"Arch Dis Child."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"41-9","DOI":"10.1016\/0887-8994(96)00115-4","article-title":"Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria.","volume":"15","author":"C Newton","year":"1996","journal-title":"Pediatr Neurol."},{"key":"ref-25","first-page":"249-52","article-title":"Experience with urea in invert sugar for the treatment of cerebral malaria.","volume":"74","author":"M Kingston","year":"1971","journal-title":"J Trop Med Hyg."},{"key":"ref-26","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-138","article-title":"Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial.","volume":"6","author":"B Namutangula","year":"2007","journal-title":"Malar J."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"7-131","DOI":"10.1111\/tmi.12313_2","article-title":"Severe malaria","volume":"19 Suppl 1","year":"2014","journal-title":"Trop Med Int Health."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"64-6","DOI":"10.1016\/s0140-6736(88)90002-5","article-title":"Single dose phenobarbitone prevents convulsions in cerebral malaria.","volume":"2","author":"N White","year":"1988","journal-title":"Lancet."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"701-6","DOI":"10.1016\/S0140-6736(99)07148-2","article-title":"Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study.","volume":"355","author":"J Crawley","year":"2000","journal-title":"Lancet."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"1086-92","DOI":"10.1016\/j.jcrc.2013.09.001","article-title":"Fosphenytoin for seizure prevention in childhood coma in Africa: a randomized clinical trial.","volume":"28","author":"S Gwer","year":"2013","journal-title":"J Crit Care."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"231-5","DOI":"10.1016\/j.pediatrneurol.2010.05.008","article-title":"Age and comedications influence levetiracetam pharmacokinetics in children.","volume":"43","author":"M Dahlin","year":"2010","journal-title":"Pediatr Neurol."},{"key":"ref-32","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-019-1766-2","article-title":"A clinical trial of enteral Levetiracetam for acute seizures in pediatric Cerebral Malaria.","volume":"19","author":"G Birbeck","year":"2019","journal-title":"BMC Pediatr."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"1031-5","DOI":"10.1111\/j.1365-2044.1995.tb05945.x","article-title":"External high frequency oscillation in normal subjects and in patients with acute respiratory failure.","volume":"50","author":"N al-Saady","year":"1995","journal-title":"Anaesthesia."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"433-9","DOI":"10.1378\/chest.107.2.433","article-title":"Effect of external chest wall oscillation on gas exchange in healthy subjects.","volume":"107","author":"T Dolmage","year":"1995","journal-title":"Chest."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"1540-9","DOI":"10.4187\/respcare.05531","article-title":"Negative-pressure ventilation in pediatric acute respiratory failure.","volume":"62","author":"A Hassinger","year":"2017","journal-title":"Respir Care."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"250-5","DOI":"10.1542\/peds.83.2.250","article-title":"Nocturnal hypoventilation in children with nonprogressive neuromuscular disease.","volume":"83","author":"J Heckmatt","year":"1989","journal-title":"Pediatrics."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"720-1","DOI":"10.1093\/bja\/74.6.720","article-title":"Use of the Hayek oscillator in a case of failed fibreoptic intubation.","volume":"74","author":"C Broomhead","year":"1995","journal-title":"Br J Anaesth."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"865-9","DOI":"10.1111\/j.1365-2044.1995.tb05853.x","article-title":"The use of the Hayek oscillator during microlaryngeal surgery.","volume":"50","author":"P Monks","year":"1995","journal-title":"Anaesthesia."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"77-85","DOI":"10.1016\/s0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics.","volume":"85","author":"P Patsalos","year":"2000","journal-title":"Pharmacol Ther."},{"key":"ref-40","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2010-8","article-title":"Emergency treatment with Levetiracetam or Phenytoin in Status Epilepticus in children-the EcLiPSE study: study protocol for a Randomised Controlled Trial.","volume":"18","author":"M Lyttle","year":"2017","journal-title":"Trials."},{"key":"ref-41","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-12-90","article-title":"Use of deferred consent for severely ill children in a multi-centre phase III trial.","volume":"12","author":"K Maitland","year":"2011","journal-title":"Trials."},{"key":"ref-42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054894","article-title":"'The words will pass with the blowing wind': staff and parent views of the deferred consent process, with prior assent, used in an emergency fluids trial in two African hospitals.","volume":"8","author":"S Molyneux","year":"2013","journal-title":"PLoS One."},{"key":"ref-43","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-015-1112-4","article-title":"Transfusion and Treatment of severe anaemia in African children (TRACT): a study protocol for a Randomised Controlled Trial.","volume":"16","author":"A Mpoya","year":"2015","journal-title":"Trials."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"206-17","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.","volume":"39","author":"L Simon","year":"2004","journal-title":"Clin Infect Dis."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"217-26","DOI":"10.1179\/146532808X335679","article-title":"Monitoring psychomotor development in a resource-limited setting: an evaluation of the kilifi developmental inventory.","volume":"28","author":"A Abubakar","year":"2008","journal-title":"Ann Trop Paediatr."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.12688\/wellcomeopenres.12747.1","article-title":"Children\u2019s Oxygen Administration Strategies Trial (COAST): a randomised controlled trial of high flow versus oxygen versus control in African children with severe pneumonia [version 1; peer review: 1 approved, 1 approved with reservations].","volume":"2","author":"K Maitland","year":"2017","journal-title":"Wellcome Open Res."},{"key":"ref-47","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-68","article-title":"Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I\/II trial design.","volume":"15","author":"L Richert","year":"2014","journal-title":"Trials."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"158-166","DOI":"10.1111\/anae.14426","article-title":"Global Capnography Project (GCAP): implementation of capnography in Malawi - an international anaesthesia quality improvement project.","volume":"74","author":"R Jooste","year":"2019","journal-title":"Anaesthesia."},{"key":"ref-49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009964.pub2","article-title":"Pre-referral rectal artesunate for severe malaria.","volume":"2014","author":"J Okebe","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"997-1008","DOI":"10.1586\/eri.10.90","article-title":"Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.","volume":"8","author":"C John","year":"2010","journal-title":"Expert Rev Anti Infect Ther."},{"key":"ref-51","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0263-6","article-title":"Management of severe paediatric malaria in resource-limited settings.","volume":"13","author":"K Maitland","year":"2015","journal-title":"BMC Med."},{"key":"ref-52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-334","article-title":"Hypoglycaemia in severe malaria, clinical associations and relationship to quinine dosage.","volume":"10","author":"G Ogetii","year":"2010","journal-title":"BMC Infect Dis."},{"key":"ref-53","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-12-31","article-title":"Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review.","volume":"12","author":"J Church","year":"2014","journal-title":"BMC Med."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"939-46","DOI":"10.1093\/cid\/cix003","article-title":"High frequency of blackwater fever among children presenting to hospital with severe febrile illnesses in Eastern Uganda.","volume":"64","author":"P Olupot-Olupot","year":"2017","journal-title":"Clin Infect Dis."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"2483-95","DOI":"10.1056\/NEJMoa1101549","article-title":"Mortality after fluid bolus in African children with severe infection.","volume":"364","author":"K Maitland","year":"2011","journal-title":"N Engl J Med."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"407-19","DOI":"10.1056\/NEJMoa1900105","article-title":"Immediate transfusion in African children with uncomplicated severe anemia.","volume":"381","author":"K Maitland","year":"2019","journal-title":"N Engl J Med."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"420-31","DOI":"10.1056\/NEJMoa1900100","article-title":"Transfusion volume for children with severe anemia in Africa.","volume":"381","author":"K Maitland","year":"2019","journal-title":"N Engl J Med."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"566-76","DOI":"10.1007\/s00134-021-06385-3","article-title":"Randomised controlled trial of oxygen therapy and high-flow nasal therapy in African children with pneumonia.","volume":"47","author":"K Maitland","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref-60","article-title":"NOVICE SPIRIT Checklist","author":"K Maitland","year":"2024"}],"container-title":["Wellcome Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-281\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-281\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-281\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T07:34:40Z","timestamp":1724312080000},"score":1,"resource":{"primary":{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-281\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":59,"URL":"https:\/\/doi.org\/10.12688\/wellcomeopenres.21403.1","relation":{"has-review":[{"id-type":"doi","id":"10.21956\/wellcomeopenres.23671.r91508","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23671.r91511","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23671.r91508","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.23671.r91511","asserted-by":"object"}]},"ISSN":["2398-502X"],"issn-type":[{"value":"2398-502X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"Indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-281\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/wellcomeopenres.23671.r91511, Alexuse Saidi, Kamuzu University of Health Sciences, Blantyre, 13 Aug 2024, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-281\/v1#referee-response-91511","order":0,"name":"referee-response-91511","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/wellcomeopenres.23671.r91508, Collins Ouma, Dr. Bernard Guyah, Biomedical Sciences and Technology, Maseno University, Kisumu and Siaya, 22 Aug 2024, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-281\/v1#referee-response-91508","order":1,"name":"referee-response-91508","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by Wellcome [209265]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}